Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant <i>Staphylococcus</i> <i>aureus</i> with Vancomycin Minimum Inhibitory Concentration > 1 µg/mL: A Systematic Review and Meta-Analysis
This systematic review and meta-analysis compares the efficacy of daptomycin and vancomycin in adult patients with bacteremia by methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) with vancomycin minimum inhibitory concentration (MIC) > 1 µg/mL. We searched the PubMed, Web of S...
Saved in:
Main Authors: | Masaru Samura (Author), Yuki Kitahiro (Author), Sho Tashiro (Author), Hiromu Moriyama (Author), Yuna Hamamura (Author), Isamu Takahata (Author), Rina Kawabe (Author), Yuki Enoki (Author), Kazuaki Taguchi (Author), Yoshio Takesue (Author), Kazuaki Matsumoto (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia-A Meta-Analysis
by: Chienhsiu Huang, et al.
Published: (2022) -
Adaptive Laboratory Evolution of <i>Staphylococcus aureus</i> Resistance to Vancomycin and Daptomycin: Mutation Patterns and Cross-Resistance
by: Vladimir Gostev, et al.
Published: (2023) -
Asymmetric Total Syntheses of Both Enantiomers of Plymuthipyranone B and Its Unnatural Analogues: Evaluation of <i>anti</i>-MRSA Activity and Its Chiral Discrimination
by: Mizuki Moriyama, et al.
Published: (2021) -
Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant <i>Enterococcus</i> <i>faecium</i> and <i>faecalis</i>
by: Katie E. Barber, et al.
Published: (2021) -
Dalbavancin, Vancomycin and Daptomycin Alone and in Combination with Cefazolin against Resistant Phenotypes of <i>Staphylococcus aureus</i> in a Pharmacokinetic/Pharmacodynamic Model
by: Jacinda C. Abdul-Mutakabbir, et al.
Published: (2020)